Exhibition

Bridge Biotherapeutics Presents Positive Results from Phase 1 Clinical Study of BBT-877 for Idiopathic Pulmonary Fibrosis (IPF) Treatments at the ERS International Congress 2019

* The study results presented at the ERS 2019 as a late breaking abstract demonstrated positive safety and tolerance in healthy volunteers * Data demonstrated LPA inhibition of BBT-877 up to 90% in multiple-ascending dose cohorts SEONGNAM, South Korea and MADRID, Sept. 29, 2019 /PRNewswire/ --...

2019-09-30 06:00 1617

CIIE starts mailing passes, first exhibit arrives

SHANGHAI, Sept. 29, 2019 /PRNewswire/ -- The first access badges for the second China International Import Expo (CIIE) were mailed to the expo's exhibitors and professional visitors byChina Post on Sept 27. First badges for CIIE sent out Ar...

2019-09-29 14:55 6558

ANTA Reveals C202/2.0 on Berlin Marathon Eve, Paying Tribute to the Race

BERLIN, Sept. 27, 2019 /PRNewswire/ -- After the debut on Sept. 26th at the Berlin Marathon Expo, ANTA Running has officially launched the latest ANTA Challenge202/2.0 limited edition SHINE & GLOW at Berlin FIRMAMENT. On the launch day, to echo the design elements for the collection, the whole st...

2019-09-29 01:04 2193
1 ... 581582583584585